nodes	percent_of_prediction	percent_of_DWPC	metapath
Cocaine—CYP2C8—Tazarotene—psoriasis	0.0903	0.0979	CbGbCtD
Cocaine—CYP3A5—Beclomethasone—psoriasis	0.0873	0.0947	CbGbCtD
Cocaine—CYP2D6—Hydroxyurea—psoriasis	0.0406	0.044	CbGbCtD
Cocaine—CYP2C8—Cholecalciferol—psoriasis	0.0385	0.0418	CbGbCtD
Cocaine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0372	0.0403	CbGbCtD
Cocaine—CYP3A7—Hydrocortisone—psoriasis	0.0372	0.0403	CbGbCtD
Cocaine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0351	0.0381	CbGbCtD
Cocaine—CYP3A7—Cyclosporine—psoriasis	0.0351	0.0381	CbGbCtD
Cocaine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0348	0.0377	CbGbCtD
Cocaine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0334	0.0362	CbGbCtD
Cocaine—CYP3A4—Calcitriol—psoriasis	0.0303	0.0329	CbGbCtD
Cocaine—CYP3A5—Hydrocortisone—psoriasis	0.0279	0.0302	CbGbCtD
Cocaine—CYP2C9—Cholecalciferol—psoriasis	0.0269	0.0292	CbGbCtD
Cocaine—CYP2C8—Hydrocortisone—psoriasis	0.0268	0.0291	CbGbCtD
Cocaine—CYP3A5—Cyclosporine—psoriasis	0.0263	0.0286	CbGbCtD
Cocaine—CYP2C8—Cyclosporine—psoriasis	0.0253	0.0275	CbGbCtD
Cocaine—CYP2D6—Cholecalciferol—psoriasis	0.0246	0.0267	CbGbCtD
Cocaine—CYP3A4—Methoxsalen—psoriasis	0.0236	0.0256	CbGbCtD
Cocaine—CYP3A7—Dexamethasone—psoriasis	0.0231	0.0251	CbGbCtD
Cocaine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0231	0.0251	CbGbCtD
Cocaine—CYP2C9—Cyclosporine—psoriasis	0.0177	0.0192	CbGbCtD
Cocaine—CYP3A5—Dexamethasone—psoriasis	0.0173	0.0188	CbGbCtD
Cocaine—CYP2C8—Dexamethasone—psoriasis	0.0167	0.0181	CbGbCtD
Cocaine—CYP2D6—Cyclosporine—psoriasis	0.0162	0.0175	CbGbCtD
Cocaine—CYP3A4—Cholecalciferol—psoriasis	0.0156	0.017	CbGbCtD
Cocaine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0136	0.0147	CbGbCtD
Cocaine—CYP3A4—Triamcinolone—psoriasis	0.0136	0.0147	CbGbCtD
Cocaine—Sensitisation—Tazarotene—psoriasis	0.0132	0.249	CcSEcCtD
Cocaine—CYP2C9—Dexamethasone—psoriasis	0.0116	0.0126	CbGbCtD
Cocaine—CYP3A4—Betamethasone—psoriasis	0.0116	0.0126	CbGbCtD
Cocaine—CYP3A4—Prednisolone—psoriasis	0.0115	0.0124	CbGbCtD
Cocaine—CYP3A4—Hydrocortisone—psoriasis	0.0109	0.0118	CbGbCtD
Cocaine—CYP3A4—Prednisone—psoriasis	0.0108	0.0117	CbGbCtD
Cocaine—CYP2D6—Dexamethasone—psoriasis	0.0106	0.0115	CbGbCtD
Cocaine—CYP3A4—Cyclosporine—psoriasis	0.0103	0.0111	CbGbCtD
Cocaine—CYP3A4—Dexamethasone—psoriasis	0.00676	0.00733	CbGbCtD
Cocaine—Ulcer—Beclomethasone—psoriasis	0.00385	0.0726	CcSEcCtD
Cocaine—Ulcer—Hydroxyurea—psoriasis	0.00187	0.0353	CcSEcCtD
Cocaine—Hypersensitivity—Calcipotriol—psoriasis	0.00168	0.0317	CcSEcCtD
Cocaine—Respiratory failure—Mycophenolic acid—psoriasis	0.00151	0.0285	CcSEcCtD
Cocaine—Mydriasis—Prednisolone—psoriasis	0.00137	0.0258	CcSEcCtD
Cocaine—Tension—Methoxsalen—psoriasis	0.00122	0.023	CcSEcCtD
Cocaine—Nervousness—Methoxsalen—psoriasis	0.00121	0.0228	CcSEcCtD
Cocaine—Respiratory failure—Mycophenolate mofetil—psoriasis	0.00119	0.0225	CcSEcCtD
Cocaine—Ulcer—Triamcinolone—psoriasis	0.00106	0.02	CcSEcCtD
Cocaine—Hypersensitivity—Clobetasol propionate—psoriasis	0.00105	0.0198	CcSEcCtD
Cocaine—Agitation—Calcitriol—psoriasis	0.00102	0.0192	CcSEcCtD
Cocaine—Tension—Acitretin—psoriasis	0.000968	0.0183	CcSEcCtD
Cocaine—Ulcer—Dexamethasone—psoriasis	0.000964	0.0182	CcSEcCtD
Cocaine—Ulcer—Betamethasone—psoriasis	0.000964	0.0182	CcSEcCtD
Cocaine—Nervousness—Acitretin—psoriasis	0.000958	0.0181	CcSEcCtD
Cocaine—Hypersensitivity—Fluocinonide—psoriasis	0.000948	0.0179	CcSEcCtD
Cocaine—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000876	0.0353	CbGpPWpGaD
Cocaine—Ulcer—Prednisone—psoriasis	0.000839	0.0158	CcSEcCtD
Cocaine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000759	0.0306	CbGpPWpGaD
Cocaine—Hypersensitivity—Methoxsalen—psoriasis	0.000748	0.0141	CcSEcCtD
Cocaine—Ulcer—Methotrexate—psoriasis	0.000701	0.0132	CcSEcCtD
Cocaine—Respiratory failure—Methotrexate—psoriasis	0.000676	0.0127	CcSEcCtD
Cocaine—Hypersensitivity—Calcitriol—psoriasis	0.000667	0.0126	CcSEcCtD
Cocaine—Tension—Mycophenolic acid—psoriasis	0.000637	0.012	CcSEcCtD
Cocaine—Nervousness—Mycophenolic acid—psoriasis	0.00063	0.0119	CcSEcCtD
Cocaine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000623	0.0251	CbGpPWpGaD
Cocaine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000618	0.0249	CbGpPWpGaD
Cocaine—Tremor—Mycophenolic acid—psoriasis	0.000608	0.0115	CcSEcCtD
Cocaine—Agitation—Mycophenolic acid—psoriasis	0.000596	0.0112	CcSEcCtD
Cocaine—Hypersensitivity—Acitretin—psoriasis	0.000593	0.0112	CcSEcCtD
Cocaine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000592	0.0112	CcSEcCtD
Cocaine—Vomiting—Calcitriol—psoriasis	0.000575	0.0109	CcSEcCtD
Cocaine—Tension—Cyclosporine—psoriasis	0.000515	0.00972	CcSEcCtD
Cocaine—Vomiting—Acitretin—psoriasis	0.000512	0.00966	CcSEcCtD
Cocaine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000511	0.00963	CcSEcCtD
Cocaine—Nervousness—Cyclosporine—psoriasis	0.00051	0.00962	CcSEcCtD
Cocaine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000503	0.0203	CbGpPWpGaD
Cocaine—Tension—Mycophenolate mofetil—psoriasis	0.000502	0.00948	CcSEcCtD
Cocaine—Nervousness—Mycophenolate mofetil—psoriasis	0.000497	0.00938	CcSEcCtD
Cocaine—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000497	0.02	CbGpPWpGaD
Cocaine—Tremor—Cyclosporine—psoriasis	0.000492	0.00928	CcSEcCtD
Cocaine—Agitation—Cyclosporine—psoriasis	0.000482	0.0091	CcSEcCtD
Cocaine—Tremor—Mycophenolate mofetil—psoriasis	0.00048	0.00905	CcSEcCtD
Cocaine—Agitation—Mycophenolate mofetil—psoriasis	0.000471	0.00888	CcSEcCtD
Cocaine—Hypersensitivity—Hydroxyurea—psoriasis	0.000466	0.00879	CcSEcCtD
Cocaine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000408	0.0164	CbGpPWpGaD
Cocaine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000407	0.0164	CbGpPWpGaD
Cocaine—Vomiting—Hydroxyurea—psoriasis	0.000402	0.00758	CcSEcCtD
Cocaine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000364	0.0146	CbGpPWpGaD
Cocaine—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000359	0.0145	CbGpPWpGaD
Cocaine—Vomiting—Mycophenolic acid—psoriasis	0.000337	0.00635	CcSEcCtD
Cocaine—Agitation—Prednisone—psoriasis	0.000319	0.00602	CcSEcCtD
Cocaine—Hypersensitivity—Cyclosporine—psoriasis	0.000316	0.00595	CcSEcCtD
Cocaine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000315	0.0127	CbGpPWpGaD
Cocaine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000311	0.0125	CbGpPWpGaD
Cocaine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000308	0.00581	CcSEcCtD
Cocaine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000295	0.0119	CbGpPWpGaD
Cocaine—Hypersensitivity—Prednisolone—psoriasis	0.000287	0.00542	CcSEcCtD
Cocaine—Hypersensitivity—Hydrocortisone—psoriasis	0.00028	0.00529	CcSEcCtD
Cocaine—Vomiting—Cyclosporine—psoriasis	0.000272	0.00514	CcSEcCtD
Cocaine—Vomiting—Mycophenolate mofetil—psoriasis	0.000266	0.00501	CcSEcCtD
Cocaine—Hypersensitivity—Triamcinolone—psoriasis	0.000264	0.00498	CcSEcCtD
Cocaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000259	0.0104	CbGpPWpGaD
Cocaine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000257	0.0103	CbGpPWpGaD
Cocaine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000256	0.0103	CbGpPWpGaD
Cocaine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000255	0.0103	CbGpPWpGaD
Cocaine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000253	0.0102	CbGpPWpGaD
Cocaine—Vomiting—Hydrocortisone—psoriasis	0.000242	0.00457	CcSEcCtD
Cocaine—Vomiting—Triamcinolone—psoriasis	0.000228	0.0043	CcSEcCtD
Cocaine—SCN5A—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000222	0.00895	CbGpPWpGaD
Cocaine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000217	0.00875	CbGpPWpGaD
Cocaine—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000217	0.00873	CbGpPWpGaD
Cocaine—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000214	0.00861	CbGpPWpGaD
Cocaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00021	0.00844	CbGpPWpGaD
Cocaine—Hypersensitivity—Prednisone—psoriasis	0.000209	0.00394	CcSEcCtD
Cocaine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000208	0.00837	CbGpPWpGaD
Cocaine—Vomiting—Betamethasone—psoriasis	0.000207	0.0039	CcSEcCtD
Cocaine—Vomiting—Dexamethasone—psoriasis	0.000207	0.0039	CcSEcCtD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000194	0.00781	CbGpPWpGaD
Cocaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000193	0.00775	CbGpPWpGaD
Cocaine—Vomiting—Prednisone—psoriasis	0.00018	0.0034	CcSEcCtD
Cocaine—CHRM1—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000176	0.00707	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—IL13—psoriasis	0.000175	0.00706	CbGpPWpGaD
Cocaine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000175	0.00705	CbGpPWpGaD
Cocaine—Hypersensitivity—Methotrexate—psoriasis	0.000174	0.00329	CcSEcCtD
Cocaine—SLC6A4—NRF2 pathway—TGFA—psoriasis	0.000174	0.007	CbGpPWpGaD
Cocaine—CHRM2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000173	0.00698	CbGpPWpGaD
Cocaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000169	0.00681	CbGpPWpGaD
Cocaine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000167	0.00672	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—CARM1—psoriasis	0.000163	0.00656	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—HCAR2—psoriasis	0.000159	0.0064	CbGpPWpGaD
Cocaine—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000157	0.00631	CbGpPWpGaD
Cocaine—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000155	0.00622	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—IL13—psoriasis	0.000153	0.00616	CbGpPWpGaD
Cocaine—Vomiting—Methotrexate—psoriasis	0.000151	0.00284	CcSEcCtD
Cocaine—SLC6A2—NRF2 pathway—TGFA—psoriasis	0.00015	0.00602	CbGpPWpGaD
Cocaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000137	0.00552	CbGpPWpGaD
Cocaine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000136	0.00546	CbGpPWpGaD
Cocaine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000135	0.00545	CbGpPWpGaD
Cocaine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000134	0.00539	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—TGFA—psoriasis	0.000132	0.00533	CbGpPWpGaD
Cocaine—SLC6A4—Monoamine Transport—TNF—psoriasis	0.000129	0.00521	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000128	0.00515	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000126	0.00509	CbGpPWpGaD
Cocaine—SLC6A3—Dopaminergic Neurogenesis—STAT3—psoriasis	0.00012	0.00483	CbGpPWpGaD
Cocaine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000118	0.00474	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000115	0.00461	CbGpPWpGaD
Cocaine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000111	0.00449	CbGpPWpGaD
Cocaine—SLC6A2—Monoamine Transport—TNF—psoriasis	0.000111	0.00448	CbGpPWpGaD
Cocaine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00011	0.00445	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.00011	0.00442	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—IL10—psoriasis	0.00011	0.00442	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000109	0.00439	CbGpPWpGaD
Cocaine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000108	0.00435	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—CARM1—psoriasis	0.000107	0.0043	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	9.88e-05	0.00398	CbGpPWpGaD
Cocaine—SLC6A3—Monoamine Transport—TNF—psoriasis	9.86e-05	0.00397	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—HCAR2—psoriasis	9.75e-05	0.00393	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—HCAR2—psoriasis	9.63e-05	0.00388	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—IL10—psoriasis	9.58e-05	0.00386	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—IL13—psoriasis	9.05e-05	0.00364	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—CP—psoriasis	8.75e-05	0.00352	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—TYK2—psoriasis	8.33e-05	0.00336	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—CCL20—psoriasis	8.26e-05	0.00332	CbGpPWpGaD
Cocaine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.21e-05	0.00331	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	7.96e-05	0.00321	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—LEP—psoriasis	7.79e-05	0.00314	CbGpPWpGaD
Cocaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.77e-05	0.00313	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—CARM1—psoriasis	7.51e-05	0.00302	CbGpPWpGaD
Cocaine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.29e-05	0.00293	CbGpPWpGaD
Cocaine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.19e-05	0.00289	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—PPARG—psoriasis	6.79e-05	0.00273	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.65e-05	0.00268	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	6.57e-05	0.00264	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—LEP—psoriasis	6.43e-05	0.00259	CbGpPWpGaD
Cocaine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	6.42e-05	0.00259	CbGpPWpGaD
Cocaine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.29e-05	0.00253	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	6e-05	0.00242	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	6e-05	0.00241	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—TYK2—psoriasis	5.95e-05	0.00239	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—VEGFA—psoriasis	5.89e-05	0.00237	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—IL10—psoriasis	5.66e-05	0.00228	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	5.6e-05	0.00226	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	5.58e-05	0.00225	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—HCAR2—psoriasis	5.51e-05	0.00222	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—TYK2—psoriasis	5.46e-05	0.0022	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—HCAR2—psoriasis	5.44e-05	0.00219	CbGpPWpGaD
Cocaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.42e-05	0.00218	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.37e-05	0.00216	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.24e-05	0.00211	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—LEP—psoriasis	5.11e-05	0.00206	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—CCL20—psoriasis	5.06e-05	0.00204	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	5.02e-05	0.00202	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—HCAR2—psoriasis	5e-05	0.00201	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—CCL20—psoriasis	5e-05	0.00201	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—HCAR2—psoriasis	4.94e-05	0.00199	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.87e-05	0.00196	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	4.87e-05	0.00196	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.79e-05	0.00193	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.69e-05	0.00189	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—NFKB1—psoriasis	4.63e-05	0.00187	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—PPARG—psoriasis	4.45e-05	0.00179	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	4.45e-05	0.00179	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—NDUFA5—psoriasis	4.36e-05	0.00176	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—NDUFA5—psoriasis	4.35e-05	0.00175	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.25e-05	0.00171	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	4.24e-05	0.00171	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—VEGFA—psoriasis	4.21e-05	0.00169	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	4.18e-05	0.00168	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—STAT3—psoriasis	4.16e-05	0.00168	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—IL6—psoriasis	4.08e-05	0.00164	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.05e-05	0.00163	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	3.97e-05	0.0016	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—TYK2—psoriasis	3.9e-05	0.00157	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—VEGFA—psoriasis	3.86e-05	0.00156	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.86e-05	0.00155	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—LEP—psoriasis	3.85e-05	0.00155	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—TYK2—psoriasis	3.84e-05	0.00155	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—CYP2S1—psoriasis	3.71e-05	0.00149	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—CYP2S1—psoriasis	3.7e-05	0.00149	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	3.65e-05	0.00147	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—TNF—psoriasis	3.6e-05	0.00145	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—LEP—psoriasis	3.59e-05	0.00145	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—NOS2—psoriasis	3.59e-05	0.00145	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	3.37e-05	0.00136	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—PPARG—psoriasis	3.36e-05	0.00135	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—NDUFA5—psoriasis	3.15e-05	0.00127	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—PPARG—psoriasis	3.13e-05	0.00126	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.09e-05	0.00125	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—NFKB1—psoriasis	3.04e-05	0.00122	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—HCAR2—psoriasis	2.96e-05	0.00119	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	2.94e-05	0.00118	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—HCAR2—psoriasis	2.92e-05	0.00117	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—IL6—psoriasis	2.91e-05	0.00117	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—JUN—psoriasis	2.88e-05	0.00116	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—CCL20—psoriasis	2.86e-05	0.00115	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—CCL20—psoriasis	2.83e-05	0.00114	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.79e-05	0.00112	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.77e-05	0.00111	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—VEGFA—psoriasis	2.76e-05	0.00111	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—TYK2—psoriasis	2.74e-05	0.0011	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—NDUFA5—psoriasis	2.73e-05	0.0011	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—STAT3—psoriasis	2.73e-05	0.0011	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—VEGFA—psoriasis	2.72e-05	0.00109	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—CYP2S1—psoriasis	2.68e-05	0.00108	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—IL6—psoriasis	2.67e-05	0.00108	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	2.62e-05	0.00106	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—CCL20—psoriasis	2.6e-05	0.00105	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—CCL20—psoriasis	2.57e-05	0.00103	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TAGAP—psoriasis	2.56e-05	0.00103	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.55e-05	0.00102	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TAGAP—psoriasis	2.53e-05	0.00102	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.51e-05	0.00101	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	2.4e-05	0.000967	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—JUN—psoriasis	2.38e-05	0.000958	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—TNF—psoriasis	2.36e-05	0.000951	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.32e-05	0.000934	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.24e-05	0.000902	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—CXCL8—psoriasis	2.23e-05	0.000898	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—NDUFA5—psoriasis	2.22e-05	0.000894	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—TNF—psoriasis	2.15e-05	0.000867	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—NFKB1—psoriasis	2.14e-05	0.00086	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.07e-05	0.000834	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—VEGFA—psoriasis	1.94e-05	0.00078	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—STAT3—psoriasis	1.92e-05	0.000773	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—IL6—psoriasis	1.91e-05	0.000768	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.91e-05	0.000767	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—CYP2S1—psoriasis	1.89e-05	0.000761	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—IL6—psoriasis	1.88e-05	0.000756	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—CARM1—psoriasis	1.81e-05	0.000729	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—CARM1—psoriasis	1.81e-05	0.000728	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.8e-05	0.000723	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.77e-05	0.000714	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—IL6—psoriasis	1.74e-05	0.0007	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—TNF—psoriasis	1.66e-05	0.000669	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—TP53—psoriasis	1.57e-05	0.000632	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—CCL20—psoriasis	1.54e-05	0.000618	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—CCL20—psoriasis	1.52e-05	0.00061	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.47e-05	0.00059	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—IL6—psoriasis	1.44e-05	0.000579	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—CXCL8—psoriasis	1.37e-05	0.000551	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.36e-05	0.000549	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—CXCL8—psoriasis	1.35e-05	0.000544	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—IL6—psoriasis	1.34e-05	0.00054	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—CARM1—psoriasis	1.31e-05	0.000527	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.25e-05	0.000502	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.00049	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—CARM1—psoriasis	1.13e-05	0.000456	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—CAT—psoriasis	1.11e-05	0.000448	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—CAT—psoriasis	1.11e-05	0.000448	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000427	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.9e-06	0.000399	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—CARM1—psoriasis	9.31e-06	0.000375	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—CARM1—psoriasis	9.23e-06	0.000371	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—APOE—psoriasis	8.65e-06	0.000348	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—APOE—psoriasis	8.64e-06	0.000348	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.62e-06	0.000347	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—SOCS1—psoriasis	8.45e-06	0.00034	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—SOCS1—psoriasis	8.35e-06	0.000336	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—TYK2—psoriasis	8.06e-06	0.000325	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—CAT—psoriasis	8.05e-06	0.000324	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—TYK2—psoriasis	7.96e-06	0.00032	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	7.73e-06	0.000311	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	7.63e-06	0.000307	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PPARG—psoriasis	7.54e-06	0.000303	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PPARG—psoriasis	7.52e-06	0.000303	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	7.02e-06	0.000283	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—CAT—psoriasis	6.97e-06	0.000281	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	6.93e-06	0.000279	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—APOE—psoriasis	6.25e-06	0.000252	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—APOE—psoriasis	6.24e-06	0.000251	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—LEP—psoriasis	6.24e-06	0.000251	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—APOE—psoriasis	6.16e-06	0.000248	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—LEP—psoriasis	6.16e-06	0.000248	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—CARM1—psoriasis	6.08e-06	0.000245	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	5.81e-06	0.000234	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	5.74e-06	0.000231	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—CAT—psoriasis	5.72e-06	0.00023	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—CAT—psoriasis	5.67e-06	0.000228	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PPARG—psoriasis	5.45e-06	0.000219	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—APOE—psoriasis	5.42e-06	0.000218	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TYK2—psoriasis	4.76e-06	0.000192	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PPARG—psoriasis	4.72e-06	0.00019	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TYK2—psoriasis	4.7e-06	0.000189	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—APOE—psoriasis	4.45e-06	0.000179	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—APOE—psoriasis	4.41e-06	0.000177	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—CXCL8—psoriasis	4.15e-06	0.000167	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—CXCL8—psoriasis	4.09e-06	0.000165	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—IL6—psoriasis	3.94e-06	0.000159	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—IL6—psoriasis	3.89e-06	0.000157	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PPARG—psoriasis	3.87e-06	0.000156	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—JUN—psoriasis	3.85e-06	0.000155	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PPARG—psoriasis	3.84e-06	0.000155	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—JUN—psoriasis	3.81e-06	0.000153	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—CAT—psoriasis	3.74e-06	0.000151	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—NFKB1—psoriasis	3.71e-06	0.000149	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—NFKB1—psoriasis	3.66e-06	0.000147	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—VEGFA—psoriasis	3.37e-06	0.000136	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—STAT3—psoriasis	3.33e-06	0.000134	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—VEGFA—psoriasis	3.32e-06	0.000134	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—STAT3—psoriasis	3.29e-06	0.000133	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—APOE—psoriasis	2.91e-06	0.000117	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TP53—psoriasis	2.54e-06	0.000102	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PPARG—psoriasis	2.53e-06	0.000102	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TP53—psoriasis	2.51e-06	0.000101	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—IL6—psoriasis	2.33e-06	9.38e-05	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—IL6—psoriasis	2.3e-06	9.26e-05	CbGpPWpGaD
